Adamis Pharmaceuticals reported $-4628020 in EBIT for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Brainstorm Cell Therapeutics BCLI:US USD -6841000 750K
Cara Therapeutics CARA:US USD -31307000 7.46M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
Glaxosmithkline GSK:US GBP 1.44B 967M
Merk MRK:US USD 4.81B 725M
Pfizer PFE:US USD 5.81B 3.89B